Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st » Globe Newswire - TCN.VN

Verisk Estimates Industry Insured Losses for Hurricane Milton Will Range Between USD 30 Billion to USD 50 Billion 16-10-2024, 17:05

General Fusion Confirms Liquid Wall Compression Technology for Commercial Magnetized Target Fusion in New Scientific Publication 11-01-2024, 21:00

Notified Files Patent for AI-Enabled Investor Relations Solutions; Aims to Transform Earnings Process for Investor Relations Officers 24-08-2023, 20:00

25-06-2024, 18:43

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Advanced TNBC

Globe Newswire25-06-2024, 18:43

18-06-2024, 14:32

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Small Cell Lung Cancer

Globe Newswire18-06-2024, 14:32

7-04-2024, 19:46

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Globe Newswire7-04-2024, 19:46

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.